Engineered CAR-T cells targeting the non-functional P2X purinoceptor 7 (P2X7) receptor as a novel treatment for ovarian cancer.
Bandara V, Niktaras VM, Willett VJ, Chapman H, Lokman NA, Macpherson AM, Napoli S, Gundsambuu B, Foeng J, Sadlon TJ, Coombs J, McColl SR, Barry SC, Oehler MK, Ricciardelli C.
Bandara V, et al. Among authors: ricciardelli c.
Clin Transl Immunology. 2024 May 23;13(5):e1512. doi: 10.1002/cti2.1512. eCollection 2024.
Clin Transl Immunology. 2024.
PMID: 38800555
Free PMC article.